HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

6th Edition of

International Public Health Conference

March 15-17, 2027 | Singapore

Huntington Disease

Huntington Disease

Huntington's disease (HD) is a rare, progressive neurological disorder characterized by the degeneration of nerve cells in the brain. It is an inherited condition caused by a faulty gene on chromosome 4, leading to the production of a mutated form of the huntingtin protein. Symptoms usually manifest in mid-adulthood, with a wide range of cognitive, motor, and psychiatric impairments. Early signs may include involuntary movements, difficulty concentrating, and mood swings. As the disease advances, individuals may experience a decline in motor skills, leading to uncontrolled movements and difficulty with coordination. Cognitive functions, such as memory and reasoning, also deteriorate, impacting daily life. HD poses significant challenges for affected individuals and their families, as the progressive nature of the disease results in increased dependency and diminished quality of life. While there is no cure for Huntington's disease, supportive care and medications can help manage symptoms and improve the patient's well-being. Genetic testing allows individuals at risk to determine whether they carry the gene mutation, aiding in family planning decisions. Research continues in the quest for effective treatments and potential breakthroughs to modify the course of the disease. Huntington's disease has far-reaching implications for affected families, underscoring the importance of genetic counseling, psychological support, and multidisciplinary care. The global medical community remains dedicated to unraveling the complexities of HD to enhance our understanding and develop targeted interventions for this challenging condition.

Committee Members
Speaker at IPHC 2027 - Kenneth R Pelletier

Kenneth R Pelletier

University of California, United States
Speaker at IPHC 2027 - Thomas J Webster

Thomas J Webster

School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Tianjin, China
Speaker at IPHC 2027 - Bernd Blobel

Bernd Blobel

University of Regensburg, Germany
IPHC 2027 Speakers
Speaker at IPHC 2027 - Bernd Blobel

Bernd Blobel

University of Regensburg
Speaker at IPHC 2027 - Iuliana Vintila

Iuliana Vintila

Dunarea de Jos University, Galati
Speaker at IPHC 2027 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences
Speaker at IPHC 2027 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

University Science Malaysia

Submit your abstract Today

YouTube
WhatsAppWhatsApp